Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Liver Failure

Liver Failure

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Liver Failure

6 trials tracked for Liver Failure.

6Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 3 Other / NA 3
  1. Phase 2 Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients Completed
  2. Phase 2 Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients Completed
  3. Phase 2 A Randomized Controlled Clinical Trial of Thymoglobulin® After Liver Transplantation Completed
  4. N/A Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study Completed
  5. N/A Superior Vena Cava and Its Relationship to Central Venous Pressure Measurements in Liver Transplantation Completed
  6. N/A Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
ABO-Incompatible Liver Transplant Outcomes Comparable in Children
Pediatrics Meta-analysis
ABO-Incompatible Liver Transplant Outcomes Comparable in Children Incompatible blood types do not lower survival in pediatric liver transplants
Meta-analysis finds similar survival and complications for ABO-incompatible pediatric liver transplants, though antibody-mediated rejection …
Children receiving liver transplants with incompatible blood types show survival rates similar to those with compatible blood types.
Sep 2, 2026
MARS treatment significantly improves creatinine and INR levels in hepatic encephalopathy patients
Nephrology Meta-analysis
MARS treatment significantly improves creatinine and INR levels in hepatic encephalopathy patients MARS Treatment May Improve Lab Markers in Liver Failure Patients
This meta-analysis evaluates the efficacy and safety of a molecular adsorbent recirculating system (MARS) for patients with hepatic encephal…
A new review suggests the MARS system may improve specific blood markers for patients with liver failure and hepatic encephalopathy.
Aug 5, 2026
ACLF-specific prediction models show better discrimination than general models for mortality risk assessment
Rheumatology Meta-analysis
ACLF-specific prediction models show better discrimination than general models for mortality risk assessment Specific prediction models show better accuracy for liver failure patients
This meta-analysis evaluated 185 studies regarding prognostic prediction models for mortality in patients with acute on chronic liver failur…
New data shows that specialized tools can better predict survival for people with acute on chronic liver failure.
Frontiers Jun 16, 2026